References
- Lineberry TW, Bostwick JM. Methamphetamine Abuse: A Perfect Storm of Complications. Mayo Clin Proc. 2006 Jan;81(1):77-84. doi: 10.4065/81.1.77
- Reddy PKV, Ng TMH, Oh EE, Moady G, Elkayan U. Clinical characteristics and Management of Methamphetamine-Associated Cardiomyopathy: State-of-the-Art Review. J Am Heart Asssoc. 2020 May 29;9(11):
e016704 . DOI: 10.1161/JAHA.120.016704 - Al-Yafeai Z, Shafaqat Ali, Brown J, et al. Cardiomyopathy-Associated Hospital Admissions Among Methamphetamine Users: Geographic and Social Disparities. JACC Advances. 2024 Mar 13;3(7):
100840 . doi: 10.1016/j.jacadv.2024.100840 - Maddox T, Januzzi J, Allen J, et al. ACC Expert Consensus Decision Pathway for Treatment of Heart Failure With Reduced Ejection Fraction: A Report of the American College of Cardiology Solution Set Oversight Committee. JACC. 2024 Apr;83(15):1444-1488. doi: 10.1016/j.jacc.2023.12.024
- Anderer S. US Drug Overdose Deaths Dropped Nearly 27% Last Year (2023). JAMA. 2025 Jul 8;334(2):107. doi: 10.1001/jama.2025.7795
DOI: https://doi.org/10.14797/mdcvj.1568 | Journal eISSN: 1947-6108
Language: English
Page range: 129 - 132
Submitted on: Jan 20, 2025
Accepted on: Jan 21, 2025
Published on: Oct 1, 2025
Published by: Houston Methodist DeBakey Heart & Vascular Center
In partnership with: Paradigm Publishing Services
© 2025 Samra Iqbal, Justin C. Cordova, James B. Young, published by Houston Methodist DeBakey Heart & Vascular Center
This work is licensed under the Creative Commons Attribution-NonCommercial 4.0 License.